| Variables | Prostate volume ≤ 45 ml (n = 89) | Prostate volume > 45 ml (n = 39) | Prostate volume ≥ 60 ml (n = 34) | p-value | |||
| N | Percent | N | Percent | N | Percent | ||
| Anesthesia technique |
| 0.291 | |||||
| SB | 70 | 22.013 | 30 | 9.434 | 25 | 7.862 |
|
| GA | 2 | 0.629 | 2 | 0.629 | 2 | 0.629 |
|
| Late complication |
|
|
|
|
|
| 0.723 |
| Stricture urethra | 3 | 0.943 | 2 | 0.629 | 1 | 0.314 |
|
| CBN | 6 | 1.887 | 0 | 0.000 | 0 | 0.000 |
|
| Hypotonic bladder | 0 | 0.000 | 0 | 0.000 | 1 | 0.314 |
|
| UTI | 0 | 0.000 | 1 | 0.314 | 0 | 0.000 |
|
| Surgical risk |
| 0.312 | |||||
| Unknown surgical risk | 4 | 1.258 | 1 | 0.314 | 0 | 0.000 |
|
| Intermediate risk | 1 | 0.314 | 0 | 0.000 | 0 | 0.000 |
|
| Long term | 4 | 1.258 | 2 | 0.629 | 0 | 0.000 |
|
| Incontinence | 5 | 1.572 | 0 | 0.000 | 1 | 0.314 | 0.207 |
| On ASA | 9 | 2.830 | 3 | 0.943 | 4 | 1.258 | 0.997 |
| Pathological report: prostate cancer | 14 | 4.403 | 2 | 0.629 | 3 | 0.943 | 0.084 |